Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/217320
Title: | The role of sodium-glucose cotransporter 2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type 2 patients |
Author: | Ibernón, Meritxell Navarro, Maru Goma, Montserrat Tango, Ariel Rap, Oana Cabrera, Cristina Sánchez, Ana Rodriguez, Neus Ruiz, Pilar |
Keywords: | Nefropaties diabètiques Diabetis no-insulinodependent Malalties del ronyó Diabetic nephropathies Non-insulin-dependent diabetes Kidney diseases |
Issue Date: | 1-May-2024 |
Publisher: | Oxford University Press (OUP) |
Abstract: | Diabetes Mellitus type 2 (DM2) leads to chronic kidney disease in a 30-40% of diabetic patients and it is the major cause of end stage renal disease (ESRD). The clinical course of diabetic kidney disease is very heterogeneous and there is a lack of agreement between clinical parameters and renal histology. Besides, lesions of non-diabetic kidney disease (NDRD) can coexist with lesions of diabetic nephropathy (DN) in two-thirds of kidney biopsies in patients with diabetes. |
Note: | Comunicació/presentació a: 61st ERA Congress, The European Renal Association, Estocolm, 23-26 maig 2024 |
Note: | Versió postprint del document publicat a: https://doi.org/10.1093/ndt/gfae069.1086 |
It is part of: | Nephrology Dialysis Transplantation, 2024, vol. 39, sup. 1, p. i1768-i1771 |
URI: | https://hdl.handle.net/2445/217320 |
Related resource: | https://doi.org/10.1093/ndt/gfae069.1086 |
ISSN: | 1460-2385 |
Appears in Collections: | Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
gfae069-1086-1626.pdf | 759.41 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.